investorscraft@gmail.com

Intrinsic ValuePing An Healthcare and Technology Company Limited (1833.HK)

Previous CloseHK$14.43
Intrinsic Value
Upside potential
Previous Close
HK$14.43

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Ping An Healthcare and Technology operates a comprehensive online healthcare ecosystem in China, integrating digital medical services with product commerce. Its core revenue model is multifaceted, generating income from online consultations, hospital referral fees, direct sales of pharmaceuticals and wellness products, and technology services for healthcare institutions. The company leverages its affiliation with Ping An Insurance Group to cross-sell services, creating a synergistic health management platform. Operating in the competitive Healthcare Information Services sector, it positions itself as a one-stop solution for consumers seeking convenient, integrated care. Its market position is strengthened by its vast technological infrastructure and data analytics capabilities, which personalize user experiences and improve service efficiency. This dual focus on B2C telehealth and B2B technology solutions provides diversified revenue streams and a defensible moat in China's rapidly digitizing healthcare market.

Revenue Profitability And Efficiency

The company reported revenue of HKD 4.81 billion for the period. It achieved a net income of HKD 81.4 million, indicating a return to profitability after prior challenges. Operating cash flow was positive at HKD 99.3 million, demonstrating an ability to generate cash from its core operations, which is a key efficiency metric for a growth-oriented technology platform.

Earnings Power And Capital Efficiency

Diluted earnings per share stood at HKD 0.075, reflecting the company's current earnings power. Capital expenditures were modest at HKD 34.2 million, suggesting a capital-light business model that does not require significant ongoing investment in physical assets, thereby supporting returns on invested capital as the platform scales.

Balance Sheet And Financial Health

The balance sheet is characterized by a strong liquidity position, with cash and equivalents of HKD 2.04 billion significantly outweighing a minimal total debt of HKD 45.0 million. This results in a robust net cash position, providing substantial financial flexibility to fund future growth initiatives and weather potential market volatility without solvency concerns.

Growth Trends And Dividend Policy

The company has initiated a dividend policy, distributing HKD 9.7 per share. This substantial payout, relative to its earnings, may signal a commitment to shareholder returns, though it is atypical for a growth-stage tech company and warrants monitoring for sustainability alongside its expansion objectives in the dynamic online healthcare market.

Valuation And Market Expectations

With a market capitalization of approximately HKD 45.3 billion, the market is valuing the company at a significant premium to its current revenue and earnings. A beta of 0.985 indicates stock volatility nearly in line with the broader market, reflecting investor perceptions of its risk profile balanced against its growth potential in the Chinese digital health sector.

Strategic Advantages And Outlook

The company's primary strategic advantage is its integration within the Ping An ecosystem, providing access to a large customer base and synergies with insurance products. The outlook hinges on its ability to monetize its platform further, expand its user engagement, and navigate the competitive and regulatory landscape of China's healthcare sector to achieve sustainable, profitable growth.

Sources

Company Annual ReportHong Kong Stock Exchange Filings

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount